Xcout Intel
Clairity, Inc.
Founded in 2020 and headquartered in Boston, Massachusetts, Clairity, Inc. is a healthcare AI company transforming breast cancer risk assessment through the first FDA-authorized artificial intelligence platform.
Subscribe to see Clairity, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Clairity, Inc. at a glance
Clairity, Inc. is a company headquartered in United States. It has raised at least $10.5M across the 2 funding rounds on record. Its most recent funding round raised $6.7M in September 2022. Xcout tracks 10 named people at Clairity, Inc., including Joan Malcolm (Chief Commercial Officer).
Clairity, Inc. leadership
- Joan MalcolmChief Commercial Officer
- Connie LehmanFounder and CEO
- Gabriella AnticiFounder, Protea Institute M.S. MIT Sloan School of Management
- Jenna BartonVice President of Finance
- Michael KearneyVice President of Market Access
- Ahmet CakirDirector of Engineering
4 more named people on record for Clairity, Inc., with roles, board committees and tenure — see the full roster →
Clairity, Inc. funding rounds
At least $10.5M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $6.7M | — | |
| SEC Form D filing | $3.8M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Clairity, Inc. competitors
A few of Clairity, Inc.'s closest competitors — see the full list of competitors and alternatives →
Kheiron Medical Technologies is a healthcare AI company that develops machine-learning software to assist with medical imaging, particularly breast cancer screening. Its products are used by radiologists and healthcare providers to help detect breast cancer and improve screening workflows.
CureMetrix is a San Diego-based medical artificial intelligence company that develops FDA-cleared software designed to assist radiologists with mammography analysis and breast health diagnostics.
PreciseDx, Inc. provides an AI-powered platform called OncoIntelligence and its specific product, PreciseBreast, to analyze tissue samples and determine breast cancer recurrence risk. The company serves oncologists, surgeons, pathologists, payors, and patients by offering objective risk stratification and phenotype insights within hours.
Aira Health is a biotechnology research company based in Boston, Massachusetts, that provides a unified AI platform for clinical trial design and protocol development.
Vara provides CE-marked artificial intelligence software designed for European breast cancer screening and diagnostics. The company's platform assists radiologists and screening programs with case triage, automated reporting, and lesion detection to improve early cancer detection and workflow efficiency.
Get Clairity, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Clairity, Inc. in Xcout Intel
- 10 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access